Stop TB says the price of J&J's tu­ber­cu­lo­sis treat­ment be­daquiline drops 55%

The Stop TB Part­ner­ship an­nounced a 55% de­crease in the price for John­son & John­son’s ver­sion of be­daquiline known as Sir­turo, which is used to treat drug-re­sis­tant tu­ber­cu­lo­sis.

The Swiss non­prof­it’s sup­ply and pro­cure­ment arm, known as the Glob­al Drug Fa­cil­i­ty (GDF), said the drug now costs around $130 per six-month treat­ment course. The or­ga­ni­za­tion al­so se­cured a 33% price re­duc­tion for Lupin’s gener­ic ver­sion of the drug for $194 for six months of treat­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER